Viewing Study NCT02575794


Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2026-02-27 @ 8:26 AM
Study NCT ID: NCT02575794
Status: COMPLETED
Last Update Posted: 2023-10-06
First Post: 2015-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Terameprocol in Treating Patients With Recurrent High Grade Glioma
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: ABTC-1401
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None NIH View